Sean Duffy
Showing 1–5 of 5 transcripts.
- a16z30 min
Fireside Chat with Sean Duffy
Amada Health, rebranding as Raising Health, recently celebrated reaching one million patients by leveraging a proprietary dataset of 25 million messages to deploy AI that augments care teams while addressing the limitations of GLP-1 medications through a dedicated lifestyle track. Co-founder Sean Duffy highlights how the company evolved from skepticism about "provider without clinics" into a foundational digital infrastructure that utilizes artificial empathy to mitigate provider shortages and lower long-term healthcare costs. By pivoting from pure software replication to a hybrid tech-life sciences model, the organization now positions itself as an essential "between-visit" partner capable of offloading longitudinal management from overwhelmed primary care clinicians.
- a16z19 min
a16z Podcast | Scaling Healthcare
Sean Duffy, Rajeev Singh, Jeff Low
Driven by the rising global burden of preventable chronic diseases, self-insured employers are pivoting from cost-shifting strategies to outcomes-based programs like Omada Health that utilize machine learning and personalized coaching to reduce claims. By integrating digital interventions as billable medical benefits and adopting revenue models tied to specific patient metrics, these initiatives have demonstrated the ability to generate 5% to 7% annual cost savings while improving workforce productivity and talent retention. This shift is further enabled by regulatory advancements, such as new CPT codes and lower thresholds for self-insurance, which allow organizations of 200 or more employees to proactively manage metabolic conditions before they escalate into expensive chronic diagnoses.
- a16z26 min
a16z Podcast | The Rise of the Digital 'Pill'
Sean Duffy, Vijay Pande, Malinka Walaliyadde, Hannah, Malinka Walaliate
Digital health has evolved into a distinct third wave of therapeutics that treats behavioral and metabolic conditions through software-driven clinical interventions validated by rigorous randomized controlled trials. Despite past skepticism from medical authorities, industry leaders are overcoming adoption barriers by demonstrating superior efficacy in areas like diabetes management and shifting payment models toward value-based outcomes. The sector is increasingly integrating with existing healthcare infrastructure to act as a clinical collaborator rather than a replacement, with artificial intelligence poised to deepen this impact while addressing global provider shortages.
- a16z17 min
a16z Podcast | The Business of Healthcare
Rajeev Singh, Vijay Pande, Sean Duffy
Driven by a projected rise in healthcare spending to 19% of GDP and a critical Type 2 diabetes epidemic, the industry is pivoting toward value-based care models led by firms like Omada and Accolade. These companies differentiate themselves through a hybrid tech-persona approach that pairs digital tools with human coaching, securing competitive moats via longitudinal clinical data rather than traditional patent protections. By rejecting fee-for-service structures in favor of outcomes-based pricing and navigating complex regulatory environments, these organizations aim to establish chronic disease management as a mandatory standard of care for a significant portion of the U.S. population within the next five years.
- Milken Institute57 min
Confronting the Obesity and Diabetes Epidemics
William Dietz, Kelly Close, Sean Duffy, Mark Hyman, Joshua Riff, Hugh Waters
This panel addresses the $3.4 trillion annual economic burden of chronic diseases in the U.S., where obesity drives nearly half the costs and disproportionately affects underserved populations through a broken primary care capacity. Experts from organizations like Cleveland Clinic, Omada, and OnDuo demonstrated that community-based food pharmacy models and digital health platforms can dramatically reverse conditions like diabetes and heart failure while reducing costs by up to 80%. To scale these life-saving interventions, the discussion emphasized an urgent need to shift from episodic "sick care" to value-based reimbursement systems that fund "food as medicine" and community health workers.